Chronic Lymphocytic Leukemia Research

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.

252

Works

IDs:OpenAlex

How has Chronic Lymphocytic Leukemia Research's publication output changed over time?

ScholarIQpublication output · 1983–2017

Output grew100% over the shown period — from 1 works in 1983 to 2 in 2017.

198319922005200820102011201220142017

What are the most-cited papers on Chronic Lymphocytic Leukemia Research?

ScholarIQmost cited works

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson, AM Fink, R. Busch, Jiřı́ Mayer, M. Hensel, Georg Hopfinger, G Hess, Ulrich von Grünhagen, Michèle Bergmann, J. Catalano, Pier Luigi Zinzani, Federico Caligaris‐Cappio, JF Seymour, A Berrébi, Ulrich Jäger, Bruno Cazin, Marek Trněný, Anne Westermann, C-M Wendtner, BF Eichhorst, Peter Staib, Andreas Bühler, Dirk Winkler, Thorsten Zenz, Sebastian Böttcher, Matthias Ritgen, Myriam Mendila, Michael Kneba, Hartmut Döhner, S. Stilgenbauer

The Lancet. 20101,874 Citations

A family of human cdc2‐related protein kinases.

Matthew Meyerson, G H Enders, Chia‐Ling Wu, Li Su, Claude Gorka, C. Nelson, Ed Harlow, Li‐Huei Tsai

S127916151. 1992921 CitationsOPEN ACCESS

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Yair Herishanu, Patricia Pérez‐Galán, Delong Liu, Angélique Biancotto, Stefania Pittaluga, Bérengère Vire, Federica Gibellini, Ndegwa Njuguna, Elinor Lee, Lawrence Stennett, Nalini Raghavachari, Poching Liu, J. Philip McCoy, Mark Raffeld, Maryalice Stetler‐Stevenson, Constance M. Yuan, Richard M. Sherry, Diane C. Arthur, Irina Marić, Therese White, Gerald E. Marti, Peter J. Munson, Wyndham H. Wilson, Adrian Wiestner

Blood. 2010818 Citations

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jörge E. Cortes, Susan Lerner, Michael J. Keating

Blood. 2008690 CitationsOPEN ACCESS

<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia

Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann, Georg Hopfinger, Manfred Hensel, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer

Journal of Clinical Oncology. 2010597 CitationsOPEN ACCESS